Roche, the maker of the main drug that would be used against a possible bird flu epidemic, is under growing pressure to allow production of generic versions of the medicine.
But the company and some outside experts say production of the drug, Tamiflu, is so complex and time-consuming that even generic makers could not quickly expand global supplies.
